Inmed Pharmaceuticals Inc. · NASDAQ:INM

ADAR1 Capital Management, LLC bought 9,569 Inmed Pharmaceuticals Inc. shares (Form 4)

Traded Oct 13 to Oct 15, 2026 · Filed Oct 15, 2026

From Oct 13 to Oct 15, 2026, ADAR1 Capital Management, LLC (10% owner) bought 9,569 Inmed Pharmaceuticals Inc. shares at an average US$1.33 for US$12,719, leaving 955,493 shares. Filed Oct 15, 2026 (Form 4).

Bought
9,569 shares
Price
US$1.33 average (US$1.32 to US$1.33)
Value
US$12,719
Holding after
955,493 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 13, 2026Common SharesBuy564US$1.33946,488Indirect
Oct 14, 2026Common SharesBuy8,021US$1.33954,509Indirect
Oct 15, 2026Common SharesBuy984US$1.32955,493Indirect

Source

Download original · View original at SEC

Related